Sweden Ends Puberty Blockers for Minors

John Stonestreet, Radio Host and Director of the Colson Center

What if it’s not inevitable.

What if the next step in the sexual revolution is not inevitable. What if a backlash to a transgender dogma that’s clearly overstepped legal and parental authority is in the air

Carl Trueman thinks so, and his prediction seems vindicated by the recent decision of Karalinska Hospital in Sweden, one of the world’s most renowned medical establishments, to end the practice of prescribing puberty-blockers to minors.

The hospital cited the high risk-to-benefit ratio of hormonal interventions in children to justify their decision. What’s called the “Dutch Protocol,” of blocking puberty and then administering cross-sex hormones, may be falling out of favor. The National Health Service has suspended new hormonal interventions for minors under 16, and there’s growing resistance across Finland too.

Chemically altering the bodies of healthy children after teaching them to hate their bodies isn’t just bad medicine; it’s malpractice. Turning around from this ledge is progress, and proves a jump over it isn’t inevitable.

Copyright 2021 by the Colson Center for Christian Worldview. Reprinted from BreakPoint.org with permission.

More Evidence Arkansas Was Right to Pass the SAFE Act

On May 5, Sweden’s Karolinska Hospital announced it would no longer give puberty blockers and cross-sex hormones to children under the age of 16.

For children ages 16 – 18, the hospital’s new policy says, “treatment may only occur within the clinical trial settings approved by the EPM (Ethical Review Agency/Swedish Institutional Review Board). The patient must receive comprehensive information about potential risks of the treatment, and a careful assessment of the patient’s maturity level must be conducted to determine if the patient is capable of taking an informed stance on, and consenting to, the treatment.”

The policy also notes that giving puberty blockers and cross-sex hormones to children “should be regarded as experimental.”

In the U.S., the FDA has never approved puberty blockers and cross-sex hormones for the purpose of gender transition. Doctors do not know the long term effects puberty blockers and cross-sex hormones can have on kids.

That is why many people equate them with experimenting on children.

That’s also why earlier this year the Arkansas Legislature voted overwhelmingly to pass Act 626 (H.B. 1570), the Save Adolescents From Experimentation Act.

This good law by Rep. Robin Lundstrum (R – Springdale) and Sen. Alan Clark (R – Lonsdale) prohibits sex-reassignment procedures on children. The law also prevents funding of sex-reassignment procedures performed on children.

Act 626 will protect children in Arkansas from being subjected to surgeries and procedures that can leave them sterilized and permanently scarred.

The fact that one of Sweden’s leading hospitals is no longer giving puberty-blockers and cross-sex hormones to kids is just more evidence that Arkansas was right to pass the SAFE Act.